Akèy › Poliradikiloneyropati demyelinizan enflamatwa kwonik › New York
Etid klinik pou Poliradikiloneyropati demyelinizan enflamatwa kwonik nan New York
8 etid pou Poliradikiloneyropati demyelinizan enflamatwa kwonik ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1605, New York
- Site Number - 1627, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- South Shore Neurologic Associates - Patchogue, Patchogue
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Dent Neurologic Institute - Amherst- Site Number : 8400039, Amherst
- Hospital for Special Surgery - Site Number : 8400041, New York
- Columbia University Irving Medical Center- Site Number : 8400003, New York
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06290141A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, New York
- TG Therapeutics Investigational Trial Site, Rochester
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 110, New York
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, New York
- Clinical Study Site, New York
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07304154A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- NYU Langone Health, New York
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06747351Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.